ArticleCancer cell international2021

Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics.

Aswani P Krishna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.